West Chester Capital Advisors, Inc Amgen Inc Transaction History

West Chester Capital Advisors, Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$230.71 - $256.74 $1.11 Million - $1.24 Million	-4,822 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $5,966 - $6,828	-30 Reduced 0.62%	4,822 $1.09 Million
Q3 2021 Nov 05, 2021	SELL	$212.27 - $248.7 $61,770 - $72,371	-291 Reduced 5.66%	4,852 $1.03 Million
Q2 2021 Jul 15, 2021	SELL	$233.58 - $259.14 $135,476 - $150,301	-580 Reduced 10.13%	5,143 $1.25 Million
Q1 2021 May 04, 2021	SELL	$221.91 - $258.6 $35,283 - $41,117	-159 Reduced 2.7%	5,723 $1.42 Million
Q4 2020 Feb 03, 2021	SELL	$216.38 - $257.67 $180,677 - $215,154	-835 Reduced 12.43%	5,882 $1.35 Million
Q3 2019 Nov 08, 2019	SELL	$174.11 - $208.62 $9,576 - $11,474	-55 Reduced 0.81%	6,717 $1.29 Million
Q2 2019 Jul 30, 2019	SELL	$166.7 - $195.41 $18,670 - $21,885	-112 Reduced 1.63%	6,772 $1.25 Million
Q1 2019 Apr 24, 2019	SELL	$180.87 - $203.88 $20,800 - $23,446	-115 Reduced 1.64%	6,884 $1.31 Million
Q4 2018 Feb 07, 2019	SELL	$178.4 - $208.25 $156,100 - $182,218	-875 Reduced 11.11%	6,999 $1.36 Million
Q3 2018 Oct 29, 2018	BUY	$185.29 - $208.89 $114,879 - $129,511	620 Added 8.55%	7,874 $1.63 Million
Q2 2018 Jul 25, 2018	SELL	$166.05 - $186.51 $112,581 - $126,453	-678 Reduced 8.55%	7,254 $1.34 Million
Q1 2018 May 04, 2018	BUY	$169.43 - $198.0 $115,890 - $135,432	684 Added 9.44%	7,932 $1.36 Million
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $1.22 Million - $1.37 Million	7,248	7,248 $1.27 Million

3,055

409M

7.19M

6.26M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of West Chester Capital Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on West Chester Capital Advisors, Inc with notifications on news.